From the Natural Resources Defense Council release:

The Food and Drug Administration must act to address the growing human health threats resulting from the overuse of antibiotics in animal feed, according to a federal court ruling issued last night. The decision stems from a lawsuit filed by the Natural Resources Defense Council, Center for Science in the Public Interest (CSPI), Food Animal Concerns Trust (FACT), Public Citizen, and Union of Concerned Scientists (UCS) last year.

“For over 35 years ago, FDA has sat idly on the sidelines largely letting the livestock industry police itself,” said Avinash Kar, NRDC health attorney.  “In that time, the overuse of antibiotics in healthy animals has skyrocketed — contributing to the rise of antibiotic-resistant bacteria that endanger human health. Today, we take a long overdue step toward ensuring that we preserve these life-saving medicines for those who need them most — people.

“These drugs are intended to cure disease, not fatten pigs and chickens,” Kar said.

In 1977, FDA concluded that feeding animals low doses of certain antibiotics used in human medicine, namely, penicillin and tetracyclines, could promote antibiotic-resistant bacteria capable of infecting people. Despite this conclusion and laws requiring that the agency move on its findings, FDA failed to take action on penicillin and tetracyclines to protect human health for the last 35 years.

The court decision noted, “In the intervening years, the scientific evidence of the risks to human health from the widespread use of antibiotics in livestock has grown.”

“This health threat has been hiding in the margins for four decades. The rise of superbugs that we see now was predicted by FDA in the 70’s,” said NRDC attorney Jen Sorenson. “Thanks to the Court’s order, drug manufacturers will finally have to do what FDA should have made them do 35 years ago: prove that their drugs are safe for human health, or take them off the market.”

The ruling compels FDA to take action on its own safety findings by withdrawing approval for most non-therapeutic uses of penicillin and tetracyclines in animal feed, unless the industry can prove in public hearings that those drug uses are safe. The ruling also makes clear that future nonbinding guidance from FDA will not excuse the Agency from its obligation to hold hearings on whether to withdraw approval for antibiotics covered by the decision.

According to the Union of Concerned Scientists, approximately 70 percent of all antibiotics used in the United States are given to healthy farm animals at low doses to promote faster growth and compensate for unsanitary living conditions — a practice that has increased over the past 60 years despite evidence that it breeds antibiotic-resistant bacteria dangerous to humans. The antibiotics, mixed into feed or water for pigs, cows, chicken, and turkeys, are used at levels too low to treat disease, leaving surviving bacteria stronger and resistant to medical treatment.

Illustration,  Wikipedia:  Schematic representation of how antibiotic resistance evolves via natural selection. The top section represents a population of bacteria before exposure to an antibiotic. The middle section shows the population directly after exposure, the phase in which selection took place. The last section shows the distribution of resistance in a new generation of bacteria. The legend indicates the resistance levels of individuals.

Pages: 1 · 2

More Articles

• Johns Hopkins Kimmel Cancer Center: Blood Test Spots Tumor-derived DNA In People With Early-stage Cancer
• The Eclipse Megamovie Project: An App to Add Images for Lasting Photo Archive
• National Institutes of Health Twitter Chat: The Importance of Clinical Trials and The Clinical Research Process
• Consumer Reports: Do Americans Take Too Many Prescription Medications? Rushed Into Taking Medications Too Quickly?
• Congressional Bills Introduced on Sexual Harassment, AMBER Alert Grants for Indian Tribes, Encouraging STEM Education, Holistic Solutions to Families in Need
• The GAO Reviews Memory Supplement Marketing and Oversight; Examples of Memory Supplement Marketing Practices and Potential Violations of Federal Requirements
• FDA Has Requested Endo Pharmaceuticals Voluntarily Remove Reformulated Opana ER From the Market
• Scientists Fear US Is ‘Losing Its Edge’ In Government-Funded Cancer Research: "I fear we are losing a generation of young, talented biomedical scientists"
• Diversity in Innovation: Documenting a Systematic and Persistent Lack of Female, Hispanic, and African American Labor Market Participation in the Innovation Sector
• Mother's Day and Mother Earth On Display At Green Festival In the Nation's Capital